OncoAlert (@oncoalert) 's Twitter Profile
OncoAlert

@oncoalert

🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨

ID: 1109128247789395968

linkhttp://www.OncoAlert360.com calendar_today22-03-2019 16:22:35

95,95K Tweet

36,36K Followers

160 Following

OncoAlert (@oncoalert) 's Twitter Profile Photo
OncoAlert
@oncoalert

5 months ago

Out on Nature Communications The OXEL study, a phase II trial in patients with triple-negative #BreastCancer post-neoadjuvant therapy ➡️demonstrated: ✅Combination of nivolumab 🧪and capecitabine significantly increased 📈peripheral immunoscore compared to either agent alone

Out on <a href="/NatureComms/">Nature Communications</a> The OXEL study, a phase II trial in patients with triple-negative #BreastCancer post-neoadjuvant therapy ➡️demonstrated: ✅Combination of nivolumab 🧪and capecitabine significantly increased 📈peripheral immunoscore compared to either agent alone